Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
BAJAJHCARE
₹322
₹320.60
₹325.40
₹272.35
₹515.90
Markets Today
Historical Performance
As of 25-08-2026 00:54, Bajaj Healthcare Ltd. share price today is ₹0, with a change of ₹-322.00 (-100.00%) from the previous close of ₹322. The stock opened at ₹324 and traded between ₹320.6 and ₹325.4, with a total traded volume of 50385 shares. The company has a market capitalization of ₹1083.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹515.9 and ₹272.35, respectively.
Bajaj Healthcare Ltd. valuation metrics include a P/E ratio of 61.5, and book value of ₹2.00. Profitability indicators show ROE of 2.95% along with a dividend yield of 0.3%. Bajaj Healthcare Ltd. has reported revenue of ₹627.83 Cr and net profit of ₹17.63 Cr.
Bajaj Healthcare Ltd. technical indicators include Day RSI at 44.11, Day MFI at 29.51, Day ADX at 9.42. Additional indicators include Commodity Channel Index (CCI) at -79.9 and Williams %R at -81.2. Momentum indicators show Day MACD at -3.13, Day MACD Signal Line at -2.07, DayATR at 10.87. Rate of Change indicators for Bajaj Healthcare Ltd. include ROC125 at -10.67 and ROC21 at 1.35.
Exponential moving averages include EMA5 at ₹323.6, EMA10 at ₹325.6, EMA12 at ₹326.3, EMA20 at ₹328.6, EMA26 at ₹329.4, EMA50 at ₹329, EMA100 at ₹332.6, EMA200 at ₹357.4. Simple moving averages include SMA5 at ₹322.5, SMA10 at ₹325.9, SMA20 at ₹327.9, SMA30 at ₹336, SMA50 at ₹332, SMA100 at ₹322.4, SMA150 at ₹328.7, SMA200 at ₹352.8.
Support levels for Bajaj Healthcare are placed at First Support ₹318.48, Second Support ₹314.97, Third Support ₹310.38. Resistance levels are seen at First Resistance ₹326.58, Second Resistance ₹331.17, Third Resistance ₹334.68. Bajaj Healthcare Ltd. shareholding pattern shows promoter holding at 58.59%, FII holding at 2.19%, DII holding at 0%, public holding at 37.3%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 165.63 | 153.06 | 161.22 | 147.91 | 148.84 |
| Operating Expense | 136.88 | 130.38 | 130.54 | 120.96 | 124.33 |
| Operating Profit | 28.75 | 22.68 | 30.68 | 26.95 | 24.51 |
| Depreciation | 7.01 | 7.63 | 7.20 | 7.08 | 5.64 |
| Interest | 6.09 | 5.57 | 5.88 | 5.56 | 5.23 |
| Tax | 2.57 | -1.40 | 3.14 | 3.51 | 2.35 |
| Net Profit | 13.70 | -22.85 | 15.67 | 11.11 | 11.83 |
₹322.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 59.2 | 59.2 | 59.2 | 59.2 | 58.3 | 58.6 |
| FII | 1 | 1.1 | 1.1 | 1.2 | 2 | 2.2 |
| DII | 2.6 | 3.1 | 3 | 2.9 | 2.9 | 1.9 |
| Public | 37.2 | 36.6 | 36.7 | 36.7 | 36.8 | 37.3 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 36.42 K | 74.39 K | 48.96% |
| Week | 38.58 K | 70.07 K | 55.06% |
| 1 Month | 72.01 K | 1.77 L | 40.78% |
| 6 Month | 1.2 L | 3.99 L | 29.96% |
Benjamin Graham Value Screen
Mid-range Performer (DVM)
Rising Net Cash Flow and Cash from Operating activity
Turnaround Companies: Loss to Profit QoQ
PEG lower than Industry PEG
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2025 | 1 | FINAL | 19 Sep, 2025 | Equity Share |
| 23 Sep, 2024 | 1 | FINAL | Equity Share | |
| 22 Sep, 2023 | 1 | FINAL | Equity Share | |
| 22 Sep, 2022 | 1.5 | FINAL | Equity Share | |
| 28 Sep, 2021 | 0.5 | FINAL | 29 Sep, 2021 | Equity Share |
| 28 Sep, 2021 | 0.5 | SPECIAL | 29 Sep, 2021 | Equity Share |
| 01 Dec, 2020 | 1.25 | INTERIM | 02 Dec, 2020 | Equity Share |
| 01 Dec, 2020 | 0.5 | SPECIAL | 02 Dec, 2020 | Equity Share |
| 19 Sep, 2018 | 1 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹526.25 | ₹6.55 | ₹205.20 | ₹15.46 | ₹518.70 | ₹100.52 |
| % Change | -2.70% | 4.97% | 4.81% | 8.26% | -3.29% | 4.99% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹511.48 | ₹305.93 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹53.97 | ₹16.01 |
| PE TTM | 115.10 | -0.30 | 51.80 | 2.40 | 28.70 | 32.50 |
| 1 Year Return | 37.97 | 524 | 55.39 | 56.92 | -23.59 | 8.81 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 23.87 | 0.77 |
Sigachi Industries Ltd.
₹ 30.45
+1.33%
Windlas Biotech Ltd.
₹ 988.00
-0.56%
Vineet Laboratories Ltd.
₹ 37.00
-2.14%
Solara Active Pharma Sciences Ltd.
₹ 628.00
+1.80%
Zim Laboratories Ltd.
₹ 124.16
-0.70%
Medico Remedies Ltd.
₹ 42.09
-1.31%
Dishman Carbogen Amcis Ltd.
₹ 173.00
-0.31%
Lasa Supergenerics Ltd.
₹ 7.33
+1.81%
Haleos Labs Ltd.
₹ 1500.00
+2.39%
Advanced Enzyme Technologies Ltd.
₹ 302.20
+0.73%
Ortin Global Ltd.
₹ 15.26
-3.96%
Brooks Laboratories Ltd.
₹ 61.70
+2.83%
RPG Life Sciences Ltd.
₹ 2638.00
+0.05%
Bafna Pharmaceuticals Ltd.
₹ 254.55
+4.99%
Alpa Laboratories Ltd.
₹ 61.20
-2.47%
SMS Pharmaceuticals Ltd.
₹ 354.00
-0.73%
Nectar Lifesciences Ltd.
₹ 10.80
+3.15%
Mangalam Drugs and Organics Ltd.
₹ 30.44
+9.97%
Indoco Remedies Ltd.
₹ 220.00
-2.78%
Ind-Swift Laboratories Ltd.
₹ 325.35
-1.29%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
-0.33%
Panacea Biotec Ltd.
₹ 406.50
-1.12%
Medicamen Biotech Ltd.
₹ 234.00
-4.31%
Themis Medicare Ltd.
₹ 120.50
+13.53%
By signing up I certify terms, conditions & privacy policy